Weight-loss drug makers announce pricing agreement with Trump
PositiveWorld Affairs
Weight-loss drug makers announce pricing agreement with Trump
In a significant move for healthcare affordability, weight-loss drug manufacturers Eli Lilly and Novo Nordisk have reached a pricing agreement with Trump that will reduce costs for Medicare and Medicaid recipients. This deal is crucial as it aims to make essential medications more accessible to millions of Americans, potentially improving health outcomes and reducing financial burdens on patients.
— via World Pulse Now AI Editorial System

